These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3129509)

  • 21. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
    Batten P; Yacoub MH; Rose ML
    Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    Basham TY; Merigan TC
    J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
    Lee YJ; Benveniste EN
    J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells.
    Wan YJ; Orrison BM; Lieberman R; Lazarovici P; Ozato K
    J Cell Physiol; 1987 Feb; 130(2):276-83. PubMed ID: 3102507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta.
    Panek RB; Benveniste EN
    J Immunol; 1995 Mar; 154(6):2846-54. PubMed ID: 7876554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different proteins are induced by alpha- and gamma-interferon in hairy cell leukemia.
    Samuels BL; Golomb HM; Brownstein BH
    J Biol Response Mod; 1987 Jun; 6(3):268-74. PubMed ID: 3110377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
    Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
    Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1.
    Love KS; Lakshmanan RR; Butterfield JH; Fox CC
    Cell Immunol; 1996 May; 170(1):85-90. PubMed ID: 8660803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
    Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of TL antigen expression. Analysis of the T18d promoter region and responses to IFN-gamma.
    Wang IM; Mehta V; Cook RG
    J Immunol; 1993 Sep; 151(5):2646-57. PubMed ID: 8360484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
    Salio M; Cella M; Vermi W; Facchetti F; Palmowski MJ; Smith CL; Shepherd D; Colonna M; Cerundolo V
    Eur J Immunol; 2003 Apr; 33(4):1052-62. PubMed ID: 12672071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation or inhibition of IFN-gamma-induced MHC class II expression by lipopolysaccharides. The roles of TNF-alpha and nitric oxide, and the importance of the sequence of signaling.
    Sicher SC; Chung GW; Vazquez MA; Lu CY
    J Immunol; 1995 Dec; 155(12):5826-34. PubMed ID: 7499872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypeptide induction by recombinant human IFN-gamma.
    Weil J; Epstein CJ; Epstein LB
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):51-60. PubMed ID: 6431271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
    Mukhopadhyay S; Peiser L; Gordon S
    J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.
    Lu Y; Ussery GD; Muncaster MM; Gallie BL; Blanck G
    Oncogene; 1994 Apr; 9(4):1015-9. PubMed ID: 8134104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A; Visonneau S; Clark SC; Santoli D
    J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.